Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 39 for:    ALECTINIB

A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02013219
Recruitment Status : Active, not recruiting
First Posted : December 17, 2013
Last Update Posted : August 6, 2019
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : September 30, 2019